Advanced search
Publication Cover
Acta Oncologica Volume 55, 2016 - Issue 2
Journal homepage
1,394
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE: Gynecological Malignancies

Variations in adjuvant chemotherapy and survival in women with epithelial ovarian cancer – a population-based study

Satyamurthy AnuradhaThe University of Queensland, School of Public Health, Brisbane, Queensland, Australia;The QIMR Berghofer Medical Research Institute, Gynaecological Cancers Group, Brisbane, Queensland, AustraliaCorrespondence[email protected]
,
Peter J. DonovanThe QIMR Berghofer Medical Research Institute, Gynaecological Cancers Group, Brisbane, Queensland, Australia
,
Penelope M. WebbThe QIMR Berghofer Medical Research Institute, Gynaecological Cancers Group, Brisbane, Queensland, Australia
,
Alison H. BrandDepartment of Gynaecological Oncology, Westmead Hospital, University of Sydney, Westmead, New South Wales, Australia
,
Jeffrey GohRoyal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
,
Michael FriedlanderDepartment of Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales, Australia
,
Martin K. OehlerDepartment of Gynaecological Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
,
Michael QuinnDepartment of Obstetrics and Gynaecology University of Melbourne, Melbourne, Victoria, Australia
,
Christopher SteerBorder Medical Oncology, Wodonga, Victoria, Australia
&
Susan J. JordanThe QIMR Berghofer Medical Research Institute, Gynaecological Cancers Group, Brisbane, Queensland, Australia
 show all
Pages 226-233 | Received 14 Mar 2014, Accepted 20 May 2015, Published online: 16 Jun 2015

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Michelle Shayne, R. Donald Harvey & Gary H. Lyman. (2021) Prophylaxis and treatment strategies for optimizing chemotherapy relative dose intensity. Expert Review of Anticancer Therapy 21:10, pages 1145-1159.
Read now
Philip Jessmon, Talia Boulanger, Wei Zhou & Pallavi Patwardhan. (2017) Epidemiology and treatment patterns of epithelial ovarian cancer. Expert Review of Anticancer Therapy 17:5, pages 427-437.
Read now

Articles from other publishers (12)

Xia Zhang, Hongjuan Zheng, Cheng Cai, Yinzi Xu, Mengzhen Xie, Qinghua Wang, Xiayun Jin & Jianfei Fu. (2023) Retrospective analysis of the impact of dose delay and reduction on outcomes of colorectal cancer patients treated with FOLFIRI‑based treatment. PeerJ 11, pages e15995.
Crossref
Anlan Cao, Brenda Cartmel, Fang-Yong Li, Linda T. Gottlieb, Maura Harrigan, Jennifer A. Ligibel, Radhika Gogoi, Peter E. Schwartz, Denise A. Esserman, Melinda L. Irwin & Leah M. Ferrucci. (2023) Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy Among Patients Treated for Ovarian Cancer. JAMA Network Open 6:8, pages e2326463.
Crossref
Alexandra L. Martin, Christelle M. Colin-Leitzinger, Sweta K. Sinha, Jing-Yi Chern & Lauren C. Peres. (2023) Impact of obesity on chemotherapy dosing of carboplatin and survival of women with ovarian cancer. British Journal of Cancer 128:12, pages 2236-2242.
Crossref
Andrew Bryant, Shaun Hiu, Patience T Kunonga, Ketankumar Gajjar, Dawn Craig, Luke Vale, Brett A Winter-Roach, Ahmed Elattar & Raj Naik. (2022) Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Cochrane Database of Systematic Reviews 2022:9.
Crossref
Soo Young Jeong, Chel Hun Choi, Tae Joong Kim, Jeong Won Lee, Byoung-Gie Kim, Duk Soo Bae & Yoo-Young Lee. (2019) Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer. Journal of Ovarian Research 13:1.
Crossref
T. Sivakumaran, L. Mileshkin, P. Grant, L. Na, A. DeFazio, M. Friedlander, A. Obermair, P.M. Webb & G. Au-Yeung. (2020) Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study. Gynecologic Oncology 158:1, pages 47-53.
Crossref
Aleksandra A. Staneva, Vanessa L. Beesley, Navin Niranjan, Alexandra F. Gibson, Ingrid Rowlands & Penelope M. Webb. (2019) “I Wasn't Gonna Let It Stop Me”: Exploring Women's Experiences of Getting Through Chemotherapy for Ovarian Cancer. Cancer Nursing 42:2, pages E31-E38.
Crossref
Yoo-Young Lee, Jeong-Won Lee, Lin Lu, Wei Xu, Alexandra Kollara, Theodore Brown, Eun-Jin Heo & Taymaa May. (2018) Impact of interval from primary cytoreductive surgery to initiation of adjuvant chemotherapy in advanced epithelial ovarian cancer. International Journal of Gynecology & Obstetrics 143:3, pages 325-332.
Crossref
Lin-Chau Chang, Chih-Fen Huang, Mei-Shu Lai, Li-Jiuan Shen, Fe-Lin Lin Wu & Wen-Fang Cheng. (2018) Prognostic factors in epithelial ovarian cancer: A population-based study. PLOS ONE 13:3, pages e0194993.
Crossref
Zunxian Yang, Hongwei Shen, Weipeng He, Linlong Ouyang, Yunyun Guo, Fang Qian, Baoduan Xu, Dan Xie & Guofen Yang. (2018) Expression of TBC1D16 Is Associated with Favorable Prognosis of Epithelial Ovarian Cancer. The Tohoku Journal of Experimental Medicine 245:3, pages 141-148.
Crossref
Veronika Seebacher, Alexander Reinthaller, Heinz Koelbl, Nicole Concin, Regina Nehoda & Stephan Polterauer. (2017) The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer ? A Retrospective Study. PLOS ONE 12:1, pages e0169272.
Crossref
Jeffrey GOH, G Raj MOHAN, Rahul LADWA, Sumitra ANANDA, Paul A COHEN & Sally BARON-HAY. (2015) Frontline treatment of epithelial ovarian cancer. Asia-Pacific Journal of Clinical Oncology 11, pages 1-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.